Introduction {#s0005}
============

With advances in technology and the more widespread use of imaging, focal liver lesions (FLLs) are being encountered increasingly during routine clinical work. FLLs can be divided into malignant and benign as the two main entities. Benign lesions comprise hemangioma, focal nodular hyperplasia (FNH), cysts, adenomas, and angioleiomyolipoma (AML). The primary hepatic malignant tumors include hepatocellular carcinoma (HCC), cholangiocarcinoma, cystadenocarcinoma, and hepatoblastoma. Among them, HCC has the highest morbidity in the primary category in Asia, whereas metastasis, the most common liver tumor in secondary disease, outnumbers primary hepatic tumors, especially in the Western world. It is imperative for malignant lesions to be treated actively and emergently. Most benign lesions are asymptomatic and are not discovered until a routine health checkup or incidental imaging examination is performed. For benign lesions, the management ranges from surveillance to biopsy when necessary. However, malignant and benign liver lesions sometimes have indistinct characteristics that make an accurate diagnosis difficult, leading to misdiagnosis, conservative treatment, or even overintervention in the course of the disease. Therefore, an accurate diagnosis that differentiates benign from malignant lesions is of importance.

Magnetic resonance imaging (MRI) offers preferable advantages over computed tomography (CT), such as improved soft tissue contrast and lesion determination [@bb0005]. The characterization of most lesions is based upon contrast enhancement patterns. However, time consumption, cost, and anaphylactic reaction are major drawbacks of MRI, especially for liver-specific contrast agents. Diffusion-weighted imaging (DWI), as a noninvasive functional imaging technique, has played an important role in lesion detection because of its high sensitivity to water molecular mobility. Besides, because of its shorter scanning time and lack of contrast medium, DWI has been widely applied in clinical practice [@bb0010], [@bb0015]. The apparent diffusion coefficient (ADC) is a quantization parameter that is calculated by DWI according to two *b* values. In tissues with higher density of cellularity or tortuosity of the extracellular space, the diffusion of water protons is impeded. In such an environment, water movement is said to be "restricted," and the ADC is lowered. By contrast, in cystic or incompact tissues, the diffusion of water is free, and the ADC is higher. Thus, DWI is a unique tool that provides information on tissue cellularity, and the ADC represents the pathophysiological changes *in vivo* in a noninvasive way.

Nevertheless, after proving that a perfusion component existed inherently in DWI voxels that has a subtle influence on the ADC measurement, intravoxel incoherent motion (IVIM) was proposed initially by Le Bihan et al. [@bb0020]. This implied that the ADC was contaminated by the bloodstream instead of reflecting the pure diffusion in each voxel; thus, the ADC obtained from a traditional monoexponential process was larger than the true diffusion in voxels, indicating that the ADC might overlap between benign and malignant lesions, thereby eclipsing its efficacy. They demonstrated that both diffusion and perfusion could be assessed quantitatively and separately by multiple *b* values encompassing sufficient low and high values, according to a biexponential model.

IVIM incorporates the pure diffusion coefficient (*D*), the pseudodiffusion coefficient (*D*^⁎^), and the perfusion fraction (*f*), respectively. IVIM has attracted much attention and has been applied for various medical purposes, such as therapeutic response evaluation [@bb0025], long-term outcome prediction [@bb0030], and chronic disease assessment [@bb0035], demonstrating great performance and excellent function. However, some studies showed that the performance of ADC is somewhat better than IVIM, being simpler and less prone to errors in the calculation process, resulting in higher efficacy in differentiation [@bb0040], [@bb0045], [@bb0050], as was shown by Zhu et al. that the differentiation performance, sensitivity, and specificity of ADC were 0.983, 96.97%, and 93.75% respectively, which were larger and higher than those for IVIM of 0.837, 87.88%, and 81.25%, respectively. Doblas et al. also supported these conclusions in a study that compared the two techniques among various liver diseases. Thus, ADC remains an important indicator in certain clinical work. The value of ADC and IVIM has not been determined because there is still no unanimous agreement on them, particularly to differentiate between benign and malignant liver lesions.

In this study, we used our data to determine the value of ADC and IVIM-related parameters to differentiate between benign and malignant solid hepatic tumors.

Materials and Methods {#s0010}
=====================

Study Selection {#s0015}
---------------

This study protocol was approved by the local ethics committee. Informed consent was acquired from all patients before the MRI examination. Between January 2016 and September 2016, clinically suspected FLLs were examined among 74 patients (62 men, 12 women) using CT or MRI. The exclusion criteria were as follows: 1) there was no liver nodule or tumor on CT or MRI; 2) the lesion diameter was less than 1 cm; 3) patients with FLLs treated by transarterial chemoembolization, radiofrequency ablation, or chemotherapy before the MRI examination; and 4) patients whose images were of unacceptable quality that interfered with the delineation of FLLs.

The final study population comprised 51 malignant FLLs and 24 benign FLLs. In the malignant group, there were 44 HCCs, 7 with metastasis. The benign group comprised 16, 6, and 2 hemangiomas, FNHs, and angioleiomyolipomas, respectively. The mean age of the malignant group was 52.31 ± 12.11 years (range: 23-79 years), whereas the mean age of the benign group was 47.50 ± 13.12 years (range: 27-84 years). Histopathological confirmation was available in 35 lesions, including 22 HCCs (13 patients after surgery and 9 patients by biopsy), 1 hemangioma, 2 angioleiomyolipomas, 7 metastases (all patients by biopsy), and 3 FNHs. In the remaining patients, the lesion was diagnosed by its typical imaging features according to the guidelines of the American Association for the Study of Liver Diseases, as well as by elevated alpha fetal protein in HCCs.

Data Acquisition {#s0020}
----------------

### Regular MRI of the Liver {#s0025}

The patients were scanned prospectively by a 3.0-T MRI scanner (Discovery 750 W; GE Healthcare, Milwaukee, WI) with a 16-element body coil. The scanning comprised axial fat-suppressed respiratory-triggered (RT) propeller T2WI \[repetition time (TR)/echo time (TE) 8000-10,000/96-100, slice/gap 5/1 mm, field of view (FOV) 40 cm\], coronal RT T2WI (TR/TE 2000/70 for coronal, slice/gap 5/1 mm, FOV 36 cm), breath-hold axial in- and opposed-phase T1WI (TR/TE 4.0/2.2-1.1, slice/gap 1/1 mm), axial 3D GRE T1WI (LAVA, TR/TE 5.25/1.7, slice thickness 1/1 mm, FOV 38 cm), and contrast injection \[0.01 mmol/kg of gadopentetate dimeglumine (*n* = 62; Magnevist, Bayer Shering Pharma, Berlin, Germany) and a 10-ml fixed dose of gadoxetic acid (*n* = 13; Primovist; Bayer Shering Pharma, Berlin, Germany)\]. Postcontrast images were collected at the arterial phase (20 seconds), portal venous phase (60 seconds), and delayed phase (180 seconds). Hepatobiliary phase images were acquired at 20 minutes in patients injected with Primovist.

### Parameters for DWI {#s0030}

RT DWI echo-planar imaging (EPI) with multiple *b* values was carried out. For patients administrated with Primovist, the DWI was performed before the hepatobiliary phase (about 20 minutes after the injection). For the remaining patients executing Magnevist administration, DWI was obtained precontrast. The image parameters were as follows: TR/TE 6000-10,000/61-64 milliseconds; FOV 40 × 40 cm; 15 slices, slice thickness/gap = 5/1 mm; spectral fat saturation; ASSET acceleration factor of two; *b* values = 0, 10, 20, 30, 50, 80, 100, 200, 400, 600, and 800 s/mm^2^; and number of excitations = 3. There were three orthogonal gradient directions. The total average acquisition time of DWI was about 5 minutes.

Image Analysis {#s0035}
--------------

To obtain ADC~total~ and IVIM-related parameters, one or several regions of interest (ROIs) were placed by an abdominal radiologist on DWI at the *b*~0~ image for each targeted lesion. If a lesion manifested homogeneity ([Figure 1](#f0005){ref-type="fig"}), a freehand ROI was drawn cautiously along the edge of the lesion to encompass as much of it as possible on the largest slice while avoiding surrounding vessels or bile ducts structures seen macrographically. If a lesion demonstrated a heterogeneous appearance ([Figure 2](#f0010){ref-type="fig"}), three identical circular ROIs were set on the largest slice to measure viable parts of tumor; care was taken to avoid necrosis or hemorrhagic areas and artifacts.Figure 1A 33-year-old man with FNH. (A-C) The lesion shows uniform mild hyperintensity on an axial fat-suppressed T1-weighted image in segment IV, homogeneously avid enhancement on the arterial phase, and slow washout on the equilibrium phase, which is a typical imaging manifestation of FNH. (D) Axial fat-suppressed T2-weighted image showing a slightly higher signal intensity. (E) For a homogeneous lesion, a freehand ROI was delineated carefully on the *b*~0~ image to encapsulate the whole lesion as far as possible. (F) After an interval of 1 week, another freehand ROI for retest is delineated to encompass the entire lesion along its border. Both ROIs seem to be identical in appearance. Their coverages are 1587 mm^2^ and 1704 mm^2^, respectively.Figure 1Figure 2A 52-year-old man with HCC. (A) Axial fat-suppressed T2-weighted image showing a well-demarcated, high--signal intensity lesion in right liver lobe, region of internal lower ring area is present. (B) The lesion shows heterogeneous hypointensity on an axial fat-suppressed T1-weighted image, with region of internal higher signal intensity representing hemorrhage. (C and D) Postcontrast images demonstrate characteristic wash-in and washout on the arterial phase and the equilibrium phase, respectively, which is a typical imaging manifestation of HCC; the central part without enhancement indicates its hemorrhagic nature. (E) For a heterogeneous lesion, three circular ROIs of the same size were set on solid and viable tumor areas on a *b*~0~ image, according to regular MRI sequences; it was meticulous to avoid internal foci of the "hemorrhagic zone". (F) After an interval of 1 week, another three identical ROIs for retest were placed. Both ROIs seem to be identical in appearance, their coverages are almost the same.Figure 2

IVIM could be expressed by a mathematical formula according to the relationship between signal intensities and *b* values:$$S_{b}/S_{0} = \left( {1 - f} \right)\ \exp.\left( {- \mathit{bD}} \right) + f\exp\left( {- \mathit{bD}^{\ast}} \right),$$where *S*~0~ = signal intensity at *b*~0~ and *S*~*b*~ = signal intensity for a given *b* value; because *D*^\*^ was markedly larger than *D*, *D* was calculated by the following equation if the *b* value was greater than 200 s/mm^2^, indicating that the perfusion content had almost decayed completely at this setting:$$\left. S_{b}/S_{0} = \exp.\left( {- \mathit{bD}} \right) \right.$$*D*^\*^ and *f* were acquired using the Levenberg-Marquardt method, which fitted *S*~*b*~ for all *b* values using Eq. [(1)](#fo0005){ref-type="disp-formula"} with a fixed *D*. Subsequently, *f* and *D*^\*^ were calculated.

Ultimately, the ADC~total~ was calculated by fitting *b*~0~ and all *b* values that were great than or equal to 200 s/mm^2^ (200, 400, 600, and 800 s/mm^2^) to a monoexponential model, and the classic ADC equation was expressed as follows:$$S_{b}/S_{0} = \exp.\left( {- b{ADC}} \right)$$

Statistical Analysis {#s0040}
--------------------

Unless specified, all data are expressed as means ± standard deviations (SDs).

The uniform sizes of the ROIs were copied for heterogeneous lesions, and freehand ROIs were drawn for homogeneous lesions after 1 week for retest analysis. The locations of the ROIs were kept the same as much as possible to avoid measurement bias.

The nonparametric Mann-Whitney *U* test was used throughout the study to compare parameters between the malignant and benign groups. Parameters showing statistical significance between the two groups were evaluated by a receiver operating characteristic curve (ROC) to assess diagnostic performance. All analyses were performed using SPSS version 19.0 (Chicago, IL). Results with *P* value less than .05 were considered statistically significant.

Results {#s0045}
=======

According to the signal intensity obtained from the 11 *b* values in our study, the relationship between them could be described by a biexponential model in each group.

The results of the IVIM parameters and ADC~total~ between these two groups are depicted in [Table 1](#t0005){ref-type="table"}. ADC~total~, *D*, and *f* were all significantly lower in the malignant group than in the benign group (*P* \< .05). The ADC~total~ values were (1.24 ± 0.24) × 10^−3^ mm^2^/s and (2.12 ± 0.54) × 10^−3^ mm^2^/s in malignant and benign group, respectively. The *D* values were (0.96 ± 0.19) × 10^−3^ mm^2^/s and (1.66 ± 0.35) × 10^−3^ mm^2^/s, respectively, and the *f* values were 19.21% ± 7.38% and 26.55% ± 14.08%, respectively. The *D*^\*^ values did not show a significant difference between these two types (*P* \> .05); the *D*^\*^ values were (73.28 ± 42.02) × 10^−3^ mm^2^/s and (97.89 ± 78.82) × 10^−3^ mm^2^/s, respectively ([Figures 3](#f0015){ref-type="fig"} and [4](#f0020){ref-type="fig"}). The comparison between HCC and hemangioma is demonstrated in [Table 2](#t0010){ref-type="table"} and shows a similar distinction between the malignant and benign groups.Figure 3IVIM DW images with 11 *b* values (in the range 0-800 s/mm^2^) from a 49-year-old man with HCC. (A) The DW image and a freehand ROI are delineated. Parametric images benefited the presentation of (B) ADC~total~ 1.58 × 10^−3^ mm^2^/s, (C) *D* 0.911 × 10^−3^ mm^2^/s, (D) *D*^\*^ 23.6 × 10^−3^ mm^2^/s, and (E) *f* 31.3%. (F) Signals decayed biexponentially with the *b* value, as shown by the fitting curve (red line). At low *b* values (\<200 s/mm^2^), the fitting curve demonstrates a large slope, whereas at large *b* values (\>200 s/mm^2^), the fitting curve demonstrates a gradually declining curve.Figure 3Figure 4IVIM DW images with 11 *b* values (in the range 0-800 s/mm^2^) from a 36-year-old man with FNH. (A) The DW image and a freehand ROI are outlined. Parametric images facilitated the presentation of (B) ADC~total~ 1.45 × 10^−3^ mm^2^/s, (C) *D* 1.07 × 10^−3^ mm^2^/s, (D) *D*^\*^ 97.5 × 10^−3^ mm^2^/s, and (E) *f* 19.7%. (F) Signals decayed biexponentially with the *b* value, as shown by the fitting curve (red line). At low *b* values (\<200 s/mm^2^), the fitting curve demonstrates a large slope, whereas at large *b* values (\>200 s/mm^2^), the fitting curve demonstrates a gradually declining curve.Figure 4Table 1Comparison of IVIM-Derived Parameters and ADC~total~ between Benign and Malignant GroupTable 1BenignMalignant*P* Value[⁎](#tf0005){ref-type="table-fn"}ADC~total~ (×10^−3^ mm^2^/s)2.12 ± 0.541.24 ± 0.24.000[\*](#tf0005){ref-type="table-fn"}*D* (×10^−3^ mm^2^/s)1.66 ± 0.350.96 ± 0.19.000[\*](#tf0005){ref-type="table-fn"}*D*[\*](#tf0005){ref-type="table-fn"} (×10^−3^ mm^2^/s)97.89 ± 78.8273.28 ± 42.02.428*f* (%)26.55 ± 14.0819.21 ± 7.38.024[\*](#tf0005){ref-type="table-fn"}[^2]Table 2Comparison of IVIM-Derived Parameters and ADC~total~ between Hemangioma and HCCTable 2HemangiomaHCC*P* Value[⁎](#tf0010){ref-type="table-fn"}ADC~total~ (×10^−3^ mm^2^/s)2.27 ± 0.511.22 ± 0.23.000[\*](#tf0010){ref-type="table-fn"}*D* (×10^−3^ mm^2^/s)1.78 ± 0.320.94 ± 0.18.000[\*](#tf0010){ref-type="table-fn"}*D*[\*](#tf0010){ref-type="table-fn"} (×10^−3^ mm^2^/s)71.57 ± 53.2975.49 ± 42.57.429*f* (%)27.99 ± 16.0218.78 ± 7.39.044[\*](#tf0010){ref-type="table-fn"}[^3]

The ROC analysis showed that ADC~total~ and *D* could be used to distinguish benign from malignant FLLs with an excellent diagnostic ability, whereas *f* was inferior to ADC~total~ and *D* ([Figure 5](#f0025){ref-type="fig"}). The maximum area under the curve (AUC) value for *D* was 0.968, followed by ADC~total~ at 0.959 and *f* at 0.647. When the threshold was set to 1.73 × 10^−3^ mm^2^/s and 1.19 × 10^−3^ mm^2^/s for ADC~total~ and *D*, respectively, the highest sensitivity was obtained correspondingly ([Table 3](#t0015){ref-type="table"}).Figure 5ROC curve generated according to the ADC and *D* values. The cutoff values for ADC and *D* were determined as 1.73 × 10^−3^ mm^2^/s and 1.19 × 10^−3^ mm^2^/s for hepatic solid benign and malignant tumors, respectively. At an ADC of 1.73 × 10^−3^ mm^2^/s, the sensitivity for the prediction was 80.80%. At a *D* value of 1.19 × 10^−3^ mm^2^/s, the sensitivity for the prediction was 92.30%. The ROC curves showed that *D* had a slightly higher AUC than ADC.Figure 5Table 3ROC Analysis of ADC~total~ and *D* for Prediction and Diagnostic Performance between Benign and Malignant GroupTable 3AUCCutoff (×10^−3^ mm^2^/s)Sensitivity (%)ADC~total~0.9591.7380.80*D*0.9681.1992.30[^4]

Discussion {#s0050}
==========

The results of the present study showed that ADC~total~, *D*, and *f*, especially the former two parameters, are useful to differentiate benign and malignant FLLs. The values for ADC~total~, *D*, and *f* were in line with, or similar to, those reported previously [@bb0045], [@bb0055], [@bb0060]. We also found that HCC and hemangioma, the most common malignant and benign liver tumors, demonstrated different results that ADC~total~, *D*, and *f* were significantly higher in hemangioma, whereas *D*^\*^ did not reach statistical significance. Different from the two *b* values from DWI that ADC is calculated from monoexponential model containing both diffusion and perfusion, and some of the IVIM-related parameters can distinguish these two components using multiple *b* values by biexponential model [@bb0055], [@bb0065].

Primovist must be injected first for adequate hepatocyte uptake; therefore, some patients were submitted to IVIM acquisition after administration of this contrast agent. Several previous studies observed that the effect of contrast medium on imaging parameters did not have statistical significance and that the image quality was not susceptible to be compromised [@bb0070], [@bb0075]; therefore, our results are credible and are not influenced by the contrast agent.

Malignant FLLs are characterized by a heterogeneous structure; therefore, it is recommended to set several ROIs of the same size in these lesions to avoid necrosis and tortuous vessels [@bb0080]. In our study, however, we observed that some of benign lesions did not manifest a homogeneous appearance. This was mainly because of the different pathological changes that could also occur in benign lesions, such as thrombus or phlebolith in hemangioma, cystic change in angioleiomyolipoma, and a central scar in FNH. Thus, the ROI placement for heterogeneous lesions in our study was based on the standard, including setting multiple ROIs to avoid covering nonsolid areas and placing manually uniform ROIs at almost identical locations each time, then calculating their average. Our results demonstrated that the SD of *D*^\*^ was largest among the parameters, which indicated that *D*^\*^ was unstable and fluctuating inherently, as was reported by other studies, suggesting that the error in the calculation of *D*^\*^ is high [@bb0085], [@bb0090] despite maintaining identical ROIs during each operation in the study.

We excluded hepatic cysts during patient selection, although some other studies included them in the benign groups [@bb0055], [@bb0060], [@bb0065], and the ADC and *D* values for benign lesions were significantly larger than those for malignant ones. The reasons that we ruled out hepatic cysts were as follow: First, it is meaningless to make a differentiation between a cyst and noncyst lesion because no contrast enhancement could be observed in a cyst, which is a typical and obvious feature that differs from solid lesions. Moreover, cysts do not actually lack perfusion. Interestingly and peculiarly, they demonstrate "blood circulation" in some cases, despite a lack of enhancement. Yamada et al. were the first to investigate the IVIM on abdominal organs and reported that the estimation of perfusion fraction of cysts was 0, meaning that cysts did not have a perfusion component [@bb0095]. By contrast, other studies reported that the *D*^\*^ and *f* of cysts were nonzero [@bb0065], [@bb0100]. It is possible that liver cysts are susceptible to be affected by a flowing-spin effect such that both the liver and the cyst fluctuate because of breath movement. It was likely that, during scanning, even though the cyst was static and the patient held their breath or breathed regularly, lasting turbulent flow resulting from inertial force might cause a flowing-spin effect. Breath-hold, RT, and free-breathing (FB) might potentially make this effect prominent for their breath capture when generating images. The misregistration resulted from a motion artifact, especially for lesions near the edge of the liver or in the anterior abdominal wall, which could also be attributed to this result even in the absence of perfusion in liver cysts. Thus, these results proved the instability of perfusion parameters from another perspective. Without cyst disturbance, it is more accurate to make a differentiation using solid hepatic tumors.

Different number of *b* values, which varied among studies, could influence the result to some extent. We used 11 *b* values, and 8 to 12 *b* values were used in other studies [@bb0050], [@bb0055], [@bb0060]. Larger numbers of small *b* values (\<200 s/mm^2^) benefit parameter measurement and higher accuracy because if there are too few of them, perfusion parameters could be underestimated [@bb0105]. Most studies comprised seven to nine small *b* values [@bb0045], [@bb0065]. Recently, a new concept termed "two key *b* values" has been suggested [@bb0110], which indicates that a "low" key *b* value can be identified around 100 to 200 s/mm^2^ for IVIM (perfusion) and a "high" one is ≥800 s/mm^2^ for non-Gaussian diffusion, contributing to shortening the acquisition time dramatically. Technologically, there are various IVIM image acquisition methods including FB and RT [@bb0055], [@bb0115]. RT is used widely and routinely, producing higher image quality; however, the parametric reproducibility of FB is higher because more excitations can be added and cyclical respiration does not result in additional signal attenuation during scanning. There is still no consensus as to which method is better because many researches have obtained excellent and reasonable results using different methods. Crucially, it should be noted that despite its widespread use and rapid image acquisition, EPI\'s intrinsic artifacts, such as distortion and ghosting, cannot be eliminated or overlooked completely. With regard to lesion sample size and categories, different studies contained different sample sizes. Our sample was comprised mainly HCC and hemangioma because of their higher morbidity; however, the lesion categories in the study of Doblas et al. were comprised of rare types [@bb0045]. The number of HCC and hemangioma cases in our group was lower than that of Yoon et al. [@bb0055] and higher than that of Ichikawa et al. [@bb0060]. However, unlike the present study, those researches did not make a comparison between them. In addition, we excluded cysts, as discussed above. The number of other FLLs, such as FNH and AML, also varied among reports because of their rarity. Besides, the underlying state of the organ, such as liver fat content, fibrotic tissue fraction, and even fasting or not, could potentially affect these discrepancies [@bb0120], [@bb0125], [@bb0130].

IVIM could be used as a valuable tool to differentiate between malignant and benign FLLs. Malignant lesions tend to have a more complicated microstructure, including hypercellularity, high nucleus-cytoplasm ratios, and polarity change due to their rapid growth and denser cells, and thus lowered degree or direction of diffusion compared with benign lesions. In addition, swelling in the cell matrix and accumulation of macromolecular substances resulting from high rates of biosynthesis cause architectural changes that could also explain the significantly higher ADC and *D* in benign lesions compared with the malignant ones, which resulted in smaller extracellular spaces and hampered diffusion degree.

Malignant lesions are prone to destroy the parenchyma, invade hepatic vessels, and generate tortuous tumor vessels and immature tissues within these lesions, which have a potential influence on the blood supply to the liver. Although thrombus or cystic change in some of benign lesions leads to a heterogeneous appearance and even arteriovenous shunts or inflammatory congestive reactions are observed, they do not disrupt the surrounding tissue and vasculature; therefore, the remainder of the liver maintains normal structure. The primary pathological change of these lesions is dilated blood sinus in hemangioma [@bb0005], disorganized hepatocytes and malformed bile ducts in FNH [@bb0135], and variations in the content of fat and thick- or thin-walled vessels mixed together in AML [@bb0140]. The different pathological changes and discrepancies in perfusion effects between the two groups could reasonably account for why *f*, the IVIM perfusion parameter, was significantly higher in benign FLLs than in malignant ones.

*D*^\*^, another perfusion parameter, was to some extent contradictive to *f*. Both of them provide perfusion information; therefore, they should have a proportional relationship. Nevertheless, they emphasize inconsistent characteristics of perfusion: *D*^\*^ is correlated with the segment length and velocity of capillary network, whereas *f* measures the fractional blood volume of microcirculation that accounts for all diffusion movement in voxels [@bb0145]. Some other studies have observed similar mismatches between *D*^\*^ and *f* [@bb0035], [@bb0040], [@bb0150], [@bb0155]. Importantly, the intrinsic instability of perfusion parameters, particularly *D*^\*^, as shown by its high SD, could be attributed to this paradox, especially when measured in malignant lesions, which are more heterogeneous. Furthermore, *f* is susceptible to be affected by other bulk flow phenomena, such as glandular secretion, which is difficult to distinguish from perfusion effects, and blood flow pattern, which is not specific to perfusion [@bb0105], [@bb0160]. Vortex and turbulent flow in a hemangioma could influence the penetration and distribution of perfusion. FNH contains bile ducts; therefore, delayed biliary excretion is possible. Additionally, the difference in TE caused by irregular respiration rates or variations in liver sizes for each patient, or accompanying by a peripheral inflammatory reaction that is characterized by vasodilation and increased permeability [@bb0165], and a background state of liver cirrhosis could also have delicate influence on parameter measurement [@bb0130]. Fortunately, the designed perfusion metric *f* × *D*^\*^ seems to show more stability and better application prospects [@bb0170], [@bb0175], resulting in this metric being recommended by several studies. Further study is warranted to confirm its efficacy.

Our results showed that ADC~total~, *D*, and *f* remain credible to discriminate between HCC and hemangioma, which contradicts the results of certain other studies [@bb0045], [@bb0050], [@bb0065]. Scattered thrombi reducing blood filling, and dilated hepatic sinusoid and irregular flowing pattern slowing down the bloodstream could contribute to this discrepancy. Besides, some studies found that perfusion of a liver tumor was related to its location and various blood supply types [@bb0050], [@bb0180]. It should also be noted that both FNH and AML display hypervascularity compared with hypovascular lesions, such as metastatic lesions; there was no apparent perfusion parametric change before and after the elimination of metastasis in the malignant group. Therefore, in some cases, excluding hypervascular lesions could reduce or mask the difference in perfusion parameters between groups.

Some studies stated that the effectiveness of ADC to diagnose and distinguish was limited to some extent because of its nonspecific features, containing both pure diffusion and perfusion [@bb0055], [@bb0175], [@bb0185]. However, other studies indicated that ADC could be a more useful biomarker than *D* to differentiate disease entities [@bb0045], [@bb0115]. Thus, there is no consensus surrounding these two values. Our results support the view that the discriminatory efficiency of *D* slightly exceeds that of ADC~total~. The sensitivity of *D* was higher than that of ADC~total~. *D* is a pure-diffusion parameter that is uniquely sensitive to molecular diffusion; therefore, for the detection of malignant lesions characterized by diffusion restriction, theoretically, *D* is more sensitive than ADC~total~. Additionally, *D* eliminates the effect of the perfusion component, whereas ADC, as a compound parameter, is more direct for *D* to reflect cell density and the extent of diffusion limitation. Therefore, the AUC of *D* was larger than that of ADC. The SD of *f* was larger than ADC~total~ and *D* despite the significant differences between malignant and benign lesions, suggesting that the practical efficacy of *f* was inferior to ADC~total~ and *D*. However, the potential value of *f* to evaluate and predict tumor response to treatment, such as that shown in hepatic chemotherapy and parotid radiation therapy, has not been eclipsed [@bb0190], [@bb0195].

Our study had several limitations. First, our study may have some selection bias. In contrast to HCC and hemangioma, the sample numbers of FNH and AML in the benign group and metastasis in the malignant group were small because of the low morbidity in the disease spectrum in daily work. Second, the pathology for some patients was not acquired. Nevertheless, the diagnostic criteria for those cases without proven histology were based on their typical imaging features and their relevant laboratory tests. Moreover, it has been noted that different histological grades of HCC could result in different parameters [@bb0200]; however, this topic was not pursued because it was beyond the scope of our study. Third, some ROIs were set in the left liver lobe. Lesions located in the left lobe are prone to be influenced by adjacent organs, such as the heart, diaphragm motion, or gastrointestinal peristalsis [@bb0205], [@bb0210]; therefore, it is recommended to select lesions located in the right liver lobe for more stable and accurate estimation [@bb0215]. Finally, judging from current IVIM scanning technologies, further studies on the effects of different acquisition methods on IVIM parameters are warranted to form standard guidelines.

Conclusion {#s0055}
==========

Our results show that the ADC~total~ and IVIM diffusion parameter *D*, which provide superior diagnostic performance, could be helpful and reliable to differentiate malignant and benign liver tumors. *D* also shows a higher sensitivity to detect malignant lesions.
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